ES521202A0 - Un procedimiento para preparar pirimidinas sustituidas. - Google Patents

Un procedimiento para preparar pirimidinas sustituidas.

Info

Publication number
ES521202A0
ES521202A0 ES521202A ES521202A ES521202A0 ES 521202 A0 ES521202 A0 ES 521202A0 ES 521202 A ES521202 A ES 521202A ES 521202 A ES521202 A ES 521202A ES 521202 A0 ES521202 A0 ES 521202A0
Authority
ES
Spain
Prior art keywords
pyrimidines
preparing
replaced
procedure
replaced pyrimidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES521202A
Other languages
English (en)
Other versions
ES8405378A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES521202A0 publication Critical patent/ES521202A0/es
Publication of ES8405378A1 publication Critical patent/ES8405378A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES521202A 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas. Expired ES8405378A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036135 1980-11-11

Publications (2)

Publication Number Publication Date
ES521202A0 true ES521202A0 (es) 1984-06-01
ES8405378A1 ES8405378A1 (es) 1984-06-01

Family

ID=10517217

Family Applications (5)

Application Number Title Priority Date Filing Date
ES506969A Expired ES8307759A1 (es) 1980-11-11 1981-11-10 Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES521204A Granted ES521204A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521201A Granted ES521201A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521203A Expired ES8405379A1 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521202A Expired ES8405378A1 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES506969A Expired ES8307759A1 (es) 1980-11-11 1981-11-10 Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES521204A Granted ES521204A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521201A Granted ES521201A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521203A Expired ES8405379A1 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.

Country Status (35)

Country Link
US (4) US4438267A (es)
EP (1) EP0051879B1 (es)
JP (1) JPS57114581A (es)
KR (1) KR880001736B1 (es)
AR (1) AR245447A1 (es)
AU (1) AU549449B2 (es)
CA (1) CA1186310A (es)
CS (1) CS273153B2 (es)
CY (1) CY1419A (es)
DD (1) DD201896A5 (es)
DE (1) DE3173752D1 (es)
DK (1) DK172884B1 (es)
EG (1) EG16107A (es)
ES (5) ES8307759A1 (es)
FI (1) FI76333C (es)
GB (1) GB2087881B (es)
GR (1) GR81317B (es)
HK (1) HK23388A (es)
HU (1) HU188762B (es)
IE (1) IE52128B1 (es)
IL (1) IL64256A (es)
IT (1) IT1210589B (es)
MC (1) MC1418A1 (es)
MY (1) MY8600678A (es)
NO (2) NO160137C (es)
NZ (1) NZ198932A (es)
PH (2) PH25053A (es)
PL (4) PL139427B1 (es)
PT (1) PT73960B (es)
RU (1) RU1819264C (es)
SG (1) SG62686G (es)
SU (4) SU1424732A3 (es)
YU (5) YU42444B (es)
ZA (1) ZA817780B (es)
ZM (1) ZM9481A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
ZA833067B (en) * 1982-05-01 1984-12-24 Wellcome Found Antibacterial compounds
DK190983A (da) * 1982-05-01 1983-11-02 Wellcome Found 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
US4590271A (en) * 1982-05-01 1986-05-20 Burroughs Wellcome Co. 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
US4587341A (en) * 1982-05-07 1986-05-06 Burroughs Wellcome Co. 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
GB8603962D0 (en) * 1986-02-18 1986-03-26 Wellcome Found Chemical compositions
LU86703A1 (fr) * 1986-12-08 1988-07-14 Oreal Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
GB8903978D0 (en) * 1989-02-22 1989-04-05 Coopers Animal Health Chemical compositions
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
CA2238521C (en) * 1995-12-04 2005-08-16 F. Hoffmann-La Roche Ag Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
WO2002010156A1 (en) * 2000-07-29 2002-02-07 Arpida Ag Benzofuran derivatives and their use as antibacterial agents
JP2005500041A (ja) * 2001-06-29 2005-01-06 アブ サイエンス 強力で選択的かつ非毒性のｃ−ｋｉｔ阻害剤
DK1401413T3 (da) * 2001-06-29 2007-03-26 Ab Science Anvendelse af tyrosinkinaseinhibitorer til behandling af allergiske sygdomme
JP2004537537A (ja) * 2001-06-29 2004-12-16 アブ サイエンス 炎症性疾患を治療するためのチロシンキナーゼ阻害剤の使用法
ATE343415T1 (de) 2001-06-29 2006-11-15 Ab Science Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen
US20040241226A1 (en) * 2001-09-20 2004-12-02 Alain Moussy Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections
ATE401078T1 (de) * 2001-09-20 2008-08-15 Ab Science Die verwendung von c-kithemmern zur förderung des haarwuchses
CA2460845A1 (en) * 2001-09-20 2003-03-27 Ab Science Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
JP2009513524A (ja) * 2003-07-11 2009-04-02 アルパイダ アーゲー 新規ベンゾフラン誘導体
RO122912B8 (ro) * 2005-02-18 2010-09-30 Arpida Ag Procedeu de preparare a unui derivat de 2h-cromen
WO2007025900A1 (en) * 2005-09-01 2007-03-08 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p3x2/3 modulators
WO2010003084A2 (en) * 2008-07-02 2010-01-07 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
EP2440533B1 (en) * 2009-06-12 2015-09-23 Socpra-Sciences Et Génie S.E.C. Guanine riboswitch binding compounds and their use as antibiotics
CN102649786B (zh) * 2011-02-28 2014-08-27 郑州福源动物药业有限公司 一种2，4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2，4-(1h，3h)嘧啶的制备方法
CN103755684B (zh) * 2014-02-10 2015-09-09 青岛蔚蓝生物股份有限公司 一种巴喹普林的制备方法
JP2022535852A (ja) * 2019-06-06 2022-08-10 ベイジン タイド ファーマシューティカル カンパニー リミテッド Ｐ２ｘ３及び／又はｐ２ｘ２／３受容体アンタゴニスト、それを含む医薬組成物及びその使用
CN110818694B (zh) * 2019-11-18 2023-04-21 上海医药工业研究院有限公司 艾拉普林中间体及其应用
EP4320104A1 (en) * 2021-04-09 2024-02-14 The Trustees of The University of Pennsylvania Control of protein expression with tmp-protac compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3956327A (en) * 1969-03-06 1976-05-11 Burroughs Wellcome Co. Method of preparing 2,4-diamino-5-benzyl pyrimidines
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
GB1468374A (en) 1974-03-06 1977-03-23 Wellcome Found Process for preparing a pyrimidine derivative
US4039543A (en) 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2730467A1 (de) * 1977-07-06 1979-01-18 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use

Also Published As

Publication number Publication date
PH25053A (en) 1991-01-28
PT73960A (en) 1981-12-01
IT8149676A0 (it) 1981-11-10
MY8600678A (en) 1986-12-31
IT1210589B (it) 1989-09-14
HK23388A (en) 1988-04-08
NO160137C (no) 1989-03-15
GR81317B (es) 1984-12-11
ES521203A0 (es) 1984-06-01
ES506969A0 (es) 1983-07-01
ES8405377A1 (es) 1984-06-01
KR880001736B1 (ko) 1988-09-10
DK172884B1 (da) 1999-09-06
YU43551B (en) 1989-08-31
YU144288A (en) 1990-04-30
ES8307759A1 (es) 1983-07-01
IL64256A (en) 1988-01-31
CS825781A2 (en) 1990-07-12
PL239280A1 (en) 1983-08-01
YU198283A (en) 1984-04-30
ES8405380A1 (es) 1984-06-01
YU266381A (en) 1984-04-30
ZA817780B (en) 1983-06-29
IE812631L (en) 1982-05-11
SU1424732A3 (ru) 1988-09-15
IE52128B1 (en) 1987-06-24
FI76333B (fi) 1988-06-30
PL139427B1 (en) 1987-01-31
SU1535379A3 (ru) 1990-01-07
RU1819264C (ru) 1993-05-30
AR245447A1 (es) 1994-01-31
DE3173752D1 (en) 1986-03-20
YU46697B (sh) 1994-04-05
YU198183A (en) 1984-04-30
SG62686G (en) 1987-03-27
PL139827B1 (en) 1987-02-28
PL139523B1 (en) 1987-01-31
EP0051879A2 (en) 1982-05-19
ES521204A0 (es) 1984-06-01
FI813546L (fi) 1982-05-12
GB2087881A (en) 1982-06-03
IL64256A0 (en) 1982-02-28
YU42444B (en) 1988-08-31
EP0051879A3 (en) 1982-08-04
US4438267A (en) 1984-03-20
ES8405379A1 (es) 1984-06-01
KR830007628A (ko) 1983-11-04
DK496681A (da) 1982-05-12
US4603136A (en) 1986-07-29
PH22654A (en) 1988-10-28
AU549449B2 (en) 1986-01-30
NZ198932A (en) 1985-05-31
CS273153B2 (en) 1991-03-12
FI76333C (fi) 1988-10-10
JPS57114581A (en) 1982-07-16
CY1419A (en) 1988-04-22
SU1306473A3 (ru) 1987-04-23
MC1418A1 (fr) 1982-10-18
ES521201A0 (es) 1984-06-01
NO1994029I1 (no) 1994-12-29
SU1318148A3 (ru) 1987-06-15
HU188762B (en) 1986-05-28
PL239279A1 (en) 1983-08-01
EG16107A (en) 1987-10-30
EP0051879B1 (en) 1986-02-05
US4761475A (en) 1988-08-02
PL233754A1 (en) 1983-08-01
DD201896A5 (de) 1983-08-17
GB2087881B (en) 1985-05-15
JPH0474351B2 (es) 1992-11-26
ZM9481A1 (en) 1983-11-21
NO160137B (no) 1988-12-05
AU7733481A (en) 1982-05-20
CA1186310A (en) 1985-04-30
YU198383A (en) 1984-04-30
ES8405378A1 (es) 1984-06-01
NO813804L (no) 1982-05-12
PL239278A1 (en) 1983-08-01
PT73960B (en) 1983-11-23
PL139828B1 (en) 1987-02-28
US4587342A (en) 1986-05-06

Similar Documents

Publication Publication Date Title
ES521204A0 (es) Un procedimiento para preparar pirimidinas sustituidas.
MX8481A (es) Procedimiento para preparar compuestos de carboestirilo.
ES500726A0 (es) Un procedimiento para preparar diaminopiridinas
ES534202A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES500727A0 (es) Un procedimiento para preparar imidazo-piridinas
ES513296A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES519652A0 (es) Un procedimiento para obtener s-adenosil-metionina.
ES517459A0 (es) Un procedimiento para preparar un dentifrico estable.
ES520364A0 (es) Un procedimiento para preparar compuestos de cefem.
ES510996A0 (es) "un procedimiento para preparar compuestos de cefem".
ES521047A0 (es) Un procedimiento para preparar compuestos de cefem.
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES527304A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES524772A0 (es) Un procedimiento para preparar fenilanilinas-n.sustituidas.
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.
ES500464A0 (es) Un procedimiento para preparar 2-halogeno-acetanilidas
ES508928A0 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
ES513070A0 (es) Procedimiento para preparar butirotiolactonas.
ES500208A0 (es) Procedimiento para preparar fenilpirazolinas pesticidas.
ES499558A0 (es) Un procedimiento para preparacion de nuevas piperidinoquinazolinas.
ES518123A0 (es) Un procedimiento para producir n-fosfonometilglicina.
ES518110A0 (es) Un procedimiento para preparar acido-hidroxi-metilglutarico.
ES517458A0 (es) Un procedimiento para preparar un dentifrico estable.